Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer

- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events - - First five patients received...

Related Keywords

Jerusalem ,Israel General ,Israel ,Montreal ,Quebec ,Canada ,United States ,Israeli ,Canadian ,Alpha Da ,Corey Miller ,Yona Keisari ,Itzhak Kelson ,Professor Of Medicine At Mcgill University ,Mcgill University ,Institute Transmedtech ,Mcgill Centre For Translational Research In Cancer ,Tel Aviv University ,Nasdaq ,Exchange Commission ,Alpha Tau Medical Ltd ,Therapeutic Endoscopy Of The Division Gastroenterology ,Lady Davis Institute ,Serious Adverse Events ,Tau Medical ,Jewish General Hospital ,Pancreatic Cancer Awareness ,Therapeutic Endoscopy ,Assistant Professor ,Associate Researcher ,Associate Member ,Mcgill Centre ,Translational Research ,Radiation Oncology ,Tau Chief Medical Officer ,Robert Den ,Diffusing Alpha Emitters Radiation Therapy ,Alpha Tau ,Tel Aviv ,Private Securities Litigation Reform Act ,United States Securities ,Markets ,